Renal Cancer - Results from #4520

Immune Checkpoint Blockade Therapy April 13, 2018

Hereditary leiomyomatosis and renal cell cancer: Cutaneous lesions & atypical fibroids April 12, 2018

Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome April 12, 2018

Identifying and managing the adverse effects of immune checkpoint blockade April 12, 2018

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial April 10, 2018

Epidemiology and screening for renal cancer April 10, 2018

Incidence and Time of Onset of Osseous Pseudoprogression in Patients With Metastatic Spine Disease From Renal Cell or Prostate Carcinoma After Treatment With Stereotactic Body Radiation Therapy April 9, 2018

New-onset insulin-dependent diabetes due to nivolumab April 9, 2018

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small cell lung cancer April 9, 2018

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma April 9, 2018

Revisiting the Prognostic Heterogeneity of AJCC Stage IV Carcinomas of the Upper Urinary Tract April 6, 2018

Nivolumab Is a Cost-Effective Second-Line Treatment for Metastatic Renal-Cell Carcinoma April 6, 2018

Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell Carcinoma April 6, 2018

Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma April 6, 2018

Imaging of Non-Prostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms April 5, 2018

Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy April 5, 2018

Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma April 5, 2018

Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer April 4, 2018

Clinical Relevance of Gene Copy Number Variation in Metastatic Clear Cell Renal Cell Carcinoma April 4, 2018

Immune-based identification of cancer patients at high risk of progression April 3, 2018

Page 227 of 457